Low-grade glioma: Supratentorial astrocytoma, oligodendroglioma, and oligoastrocytoma in adults

被引：18

作者：

Ashby L.S. ^{[1
]}

Shapiro W.R. ^{[1
]}

机构：

[1] Barrow Neurological Institute, Phoenix, AZ 85013

来源：

Current Neurology and Neuroscience Reports | 2004年 / 4卷 / 3期

关键词：

Astrocytoma; Oligodendroglioma; Gross Total Resection; Oligodendroglial Tumor; North Central Cancer Treatment Group;

D O I：

10.1007/s11910-004-0041-5

中图分类号：

学科分类号：

摘要：

Low-grade glioma is not a single diagnosis but a category of biologically diverse neoplasms. They are indolent, progressive, and, following anaplastic transformation, invariably fatal. Neuro-oncologists have not established a treatment standard for these tumors. However, it is clear that "low-grade" is not synonymous with " benign," and treatment is required sometime in the course of the disease. Previously, achieving a consensus had been limited by a lack of class I evidence. Physicians treated patients based on retrospective series and personal experience. Currently, results from prospective clinical trials are becoming available. These studies have provided data that may serve as treatment guidelines. Additional results regarding the identification of prognostic variables have raised more questions to be answered. Attention is now directed to the importance of translational research to better define these neoplasms. In the future, it will be necessary to distinguish among low-grade gliomas and identify therapies that may differ between them. Copyright © 2004 by Current Science Inc.

引用

页码：211 / 217

页数：6

共 50 条

[31]

Schmidt M.H., Berger M.S., Lamborn K.R., Et al., Repeated operations for infiltrative low-grade gliomas without intervening therapy, J. Neurosurg., 98, pp. 1165-1169, (2003)

[32]

Chamberlain M.C., Murovic J.A., Levin V.A., Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas, Neurology, 38, pp. 1371-1374, (1988)

[33]

Kondziolka D., Lunsford L.D., Martinez A.J., Unreliability of contemporary neurodiagnostic imaging in evaluating suspect adult supratentorial (low-grade) astrocytoma, J. Neurosurg., 79, pp. 533-536, (1993)

[34]

Reiche W., Grunwald I., Hermann K., Et al., Oligodendrogliomas: A comparison of CT and MR imaging features with histological malignancy grading in twenty cases: A pathoradiological study, Acta Radiologica., 43, pp. 474-482, (2002)

[35]

Scott J.N., Brasher P.M., Sevick R.J., Et al., How often are non-enhancing supratentorial gliomas malignant? A population study, Neurology, 59, pp. 947-949, (2002)

[36]

Tatter S.B., Neurosurgical management of low- and intermediate-grade gliomas, Semin. Radiat. Oncol., 11, pp. 113-123, (2001)

[37]

Whittle I.R., Surgery for gliomas, Curr. Opin. Neurol., 15, pp. 663-669, (2002)

[38]

Karim A.B., Maat B., Hatlevoll R., Et al., A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844, Int. J. Radiat. Oncol. Biol. Phys., 36, pp. 549-556, (1996)

[39]

Pignatti F., van den Bent M., Curran D., Et al., Prognostic factors for survival in adult patients with cerebral low-grade glioma, J. Clin. Oncol., 20, pp. 2076-2084, (2002)

[40]

Shaw E., Arusell R., Scheithauer B., Et al., Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: Initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study, J. Clin. Oncol., 20, pp. 2267-2276, (2002)

← 1 2 3 4 5 →